RACHEL GASQUE, APRN
Nurse Practitioner · CONWAY, SC
Individual Active NPI 1619481397
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,209 | 546,443 | $49,871,182 | $14,596,779 | $11,598,429 |
| 2023 | 405 | 90,893 | $7,431,161 | $2,123,338 | $1,692,125 |
| 2022 | 23 | 33 | $2,796 | $553 | $302 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1306 | Injection, inclisiran, 1 mg | 69,296 | $12 | $9 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 62,400 | $21 | $17 |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 35,910 | $11 | $8 |
| J0897 | Injection, denosumab, 1 mg | 33,240 | $25 | $20 |
| J2356 | Injection, tezepelumab-ekko, 1 mg | 21,210 | $18 | $14 |
| J0485 | Injection, belatacept, 1 mg | 21,000 | $4 | $3 |
| J2182 | Injection, mepolizumab, 1 mg | 20,200 | $30 | $24 |
| J2357 | Injection, omalizumab, 5 mg | 19,305 | $37 | $30 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 15,750 | $1 | $1 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 15,490 | $45 | $35 |
| J2350 | Injection, ocrelizumab, 1 mg | 13,200 | $56 | $45 |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 9,200 | $17 | $14 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Nurse Practitioner | 363L00000X | ✓ | 21601 | SC |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Nurse Practitioner providers in South Carolina
- NPI 1578148441
- NPI 1225659394
- NPI 1871106955
- NPI 1316930324
- NPI 1659468114
- NPI 1437258191
- NPI 1942317037
- NPI 1821528571
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.